Concepedia

Callum M. Sloss

CM

28

Publications

1.8K

Citations

20

H-Index

2001

Active since

Affiliations

ImmunoGen (United States)(Current)

Roswell Park Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

University of Strathclyde

Callum M. Sloss is an author at ImmunoGen (United States) specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

2001–2024

28

Publications

28

Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

Andrea Boni, Alexandria P. Cogdill, Ping Dang et al. · Cancer Research · 2010 · 737 citations

MAP Kinase Phosphatase-2 Plays a Critical Role in Response to Infection by Leishmania mexicana

Mashael S. Al-Mutairi, Laurence Cadalbert, H. Adrienne McGachy et al. · PLoS Pathogens · 2010 · 84 citations · Full text

IMGN779, a Novel CD33-Targeting Antibody–Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML

Yelena Kovtun, Paul Noordhuis, Kathleen R. Whiteman et al. · Molecular Cancer Therapeutics · 2018 · 77 citations · Full text

Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance

F Wang, R Liu, S W Lee et al. · Oncogene · 2006 · 74 citations · Full text

, , +9

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Callum M. Sloss, Fang Wang, Rong Liu et al. · Clinical Cancer Research · 2008 · 69 citations · Full text

Rows per page

1–5 of 28